Clinical trial Recruiting at 1 site Interventional

Boosting precision cancer testing for veterans with advanced prostate or lung cancer

Official title: Multilevel Veteran-centric Intervention to Improve Precision Oncology

Run by VA Office of Research and Development · NCT06825715 · Data updated 2026-11-12

This program will try a three-part approach—short patient education, provider feedback, and an easier EMR ordering system—to increase molecular testing for veterans with advanced prostate or lung cancer at eight VA centers.

Quick facts

Study typeInterventional
SexAll
Enrollment2653 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (New York, New York)
StatusRecruiting
StartedJuly 2, 2025
Main results expectedFebruary 28, 2029
Study endsFebruary 28, 2030
Registry record updatedJuly 7, 2026
Trial IDNCT06825715 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Veterans with advanced prostate or lung cancer who are seen in oncology clinics at one of the participating VA medical centers are ideal candidates.

Probably not a fit

Patients whose cancer did not originate in the prostate or lung, or veterans who do not receive care at the participating VA sites, are not eligible and will not directly benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-methods type I hybrid effectiveness-implementation project rolls out a multilevel intervention at eight VA centers chosen for diversity in rurality, region, cancer volume, and care mode. The intervention combines a 5-minute patient educational video accessible by QR code, a 45-minute academic detailing session plus individualized audit-and-feedback for providers, and an EMR consult function that streamlines ordering and returning molecular test results. The investigators use the Theoretical Domains Framework and prior analyses to guide implementation and will collect validated survey measures from stakeholders. The primary outcome is the proportion of eligible veterans who receive guideline-recommended molecular testing, with mixed-methods evaluation of implementation processes and site-level changes.

Why it matters

Potential benefit: If successful, more veterans could receive guideline-recommended molecular testing, improving access to targeted therapies and potentially improving survival and quality of life.

How similar studies have gone: Molecular testing and EMR-based ordering have improved care in prior work, and education plus audit-and-feedback have shown mixed but often positive effects, but combining all three components in a multilevel VA implementation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients in the VA with cancer of the lung or prostate who are seen in the oncology clinic

Exclusion Criteria:

* Cancer that did not originate in the prostate or the lung

Where it's running

  • VA NY Harbor Healthcare System, New York, NY
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Daniel J Becker, MD — VA NY Harbor Healthcare System, New York, NY
  • Study coordinator: Antoinette Vo, BA MA
  • Email: antoinette.vo@va.gov
  • Phone: (212) 686-7500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Virus-linked Tumor Microenvironment in CancerPatients

    This study tests how viruses influence the tumor environment across several cancers to understand how Treatments might work better.

    Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06471296

  • taVNS for knee osteoarthritis in Veterans

    This study tests whether home-based transcutaneous auricular vagus nerve stimulation (taVNS) can relieve knee OA pain and reduce inflammation in Veterans, comparing it with corticosteroid injections.

    Recruiting VA Office of Research and Development · Decatur, Georgia · NCT07804199

  • Honest, Open, Proud for justice-involved veterans

    This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.

    Recruiting VA Office of Research and Development · Bedford, Massachusetts · NCT07742722

  • Tailor a Hand Hygiene Bundle for Acute Mental Health Care

    We’re testing a new hand hygiene approach in VA mental health inpatient units to see if a tailored bundle and non-alcohol sanitizer can improve cleanliness and reduce infections.

    Recruiting at 4 sites VA Office of Research and Development · Hines, Illinois and 3 other locations · NCT07607145

  • Using smartphone video to measure knee movement in osteoarthritis

    This project will test whether a smartphone video system called OpenCap can measure knee movement and mechanics in people with early knee osteoarthritis and how those measurements compare with lab motion capture, symptoms, and knee imaging.

    Recruiting VA Office of Research and Development · Palo Alto, California · NCT07580222

  • Care coordination with passive mobile monitoring to help veterans with serious mental illness

    This project tests a care-coordination approach that uses passive mobile data and peer coaching to help veterans with serious mental illness avoid emergency care and stay connected with their care teams.

    Recruiting at 2 sites VA Office of Research and Development · West Los Angeles, California and 1 other locations · NCT07549178

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.